Obstructive sleep apnoea (OSA) is a common and debilitating condition and can affect people at any age, although is most prevalent from middle age onwards. It is characterised by loud snoring with episodes of silence.

In OSA, the upper part of the air passage behind the tongue narrows and often blocks during sleep, causing an interruption in breathing. Each brief awakening required to reopen the airway passage destroys the normal sleep pattern and sleep is severely disrupted. This prevents the sleeper from enjoying sufficient deep sleep to feel refreshed and energetic the next day.

Sleep apnoea’s short-to-medium term symptoms include chronic fatigue, mental confusion and lower testosterone count, which reduces libido, and is associated with erectile dysfunction but is also linked to many other serious conditions if left untreated over the long term. OSA can also be a contributing factor to hypertension, stroke, diabetes, heart disease and, ultimately, heart failure.

Continuous positive airway pressure (CPAP) is the most effective and non-invasive treatment offered to OSA sufferers. This therapy is designed to stop the air passage from narrowing or collapsing during sleep by acting as a splint.

To find out more about CPAP call on 2134 4345, send an e-mail to admin@technoline-mt.com or visit www.technoline-mt.com.